Glycomet GP 3/850 Tablet PR is a combination oral antidiabetic medicine containing Glimepiride 3mg, which stimulates insulin release from the pancreas, and Metformin Hydrochloride Prolonged Release 850mg, which decreases glucose production in the liver and improves insulin sensitivity.
This dual-action therapy helps achieve better glycemic control in adults with Type 2 Diabetes Mellitus and reduces the risk of long-term diabetes-related complications affecting the kidneys, eyes, nerves, and cardiovascular system. It should be taken with food, along with a healthy diet, regular exercise, and routine blood glucose monitoring, as directed by a healthcare professional.
⭐ Key Features
- Combination of Glimepiride 3mg + Metformin PR 850mg
- Helps effectively control blood sugar levels
- Improves insulin secretion and insulin sensitivity
- Prolonged-release metformin for sustained glucose control
- Helps reduce the risk of diabetes-related complications
- Prescription-only medicine
- Manufactured by USV Pvt. Ltd.
